Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
Epitranscriptomic modifications in programmed cell death: mechanistic insights and implications for liver diseases
Lulu Chen1, Yajuan Lu1, Aoli Deng1
1Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, 310014, Zhejiang, China.
Epitranscriptomic modifications regulate programmed cell death (PCD) in liver diseases. Understanding these RNA changes offers new therapeutic targets for conditions like MASLD, viral hepatitis, and HCC.
Area of Science:
- Molecular Biology
- Cell Biology
- Hepatology
Background:
- Epitranscriptomic modifications dynamically regulate RNA metabolism.
- Aberrant epitranscriptomic changes are implicated in liver disease pathogenesis.
- These modifications impact programmed cell death (PCD) pathways.
Purpose of the Study:
- To review the molecular mechanisms of epitranscriptomic modifications in PCD.
- To elucidate the role of epitranscriptomics in various liver diseases.
- To summarize current therapeutic strategies targeting epitranscriptomic modifications.
Main Methods:
- Systematic literature review.
- Analysis of molecular mechanisms linking epitranscriptomics and PCD.
- Review of drug targets and therapeutic approaches.
Main Results:
- Epitranscriptomic modifications finely tune RNA networks controlling PCD.
- Dysregulation contributes to MASLD, viral hepatitis, ALD, fibrosis, and HCC.
- These modifications present potential biomarkers and therapeutic targets.
Conclusions:
- Epitranscriptomic regulation of PCD is crucial in liver disease.
- Targeting epitranscriptomic modifications offers novel treatment avenues.
- This field provides directions for precision medicine in liver disorders.
Related Concept Videos
Cell Specific Gene Expression
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Apoptosis
Regulation of the Unfolded Protein Response
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

